Image

Treating Civilian Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation (ciTBI-HDtDCS)

Recruiting
18 - 85 years of age
Both
Phase 1/2

Powered by AI

Overview

The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., pre-supplementary motor area) thought to aid in memory will improve verbal retrieval in civilian (non-military, non-veteran) participants with histories of traumatic brain injuries. The primary outcome measures are neuropsychological assessments of verbal retrieval, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures. Additionally, the study will examine the degree to which baseline assessments of cognition, concussion history, structural brain imaging, and EEG predict responses to treatment over time, both on assessments administered within the intervention period and at follow-up.

Description

Using two treatment arms, the study will examine improvement of verbal retrieval and other cognitive deficits associated with remote traumatic brain injury by comparing (1) 1 milliamp transcranial direct current stimulation (tDCS) active treatment applied to presupplementary motor area for 20 minutes over 10 sessions to (2) sham tDCS following the same schedule. Additionally, after completing the initial active or sham treatment and 2-month follow-up testing sessions, participants will be invited back for newly assigned treatment conditions, 20 minutes over 10 sessions and will be re-evaluated at 2-months follow-up testing sessions.

Civilians with histories of traumatic brain injuries and observed cognitive deficits will be randomly assigned to one of the two treatment arms (and re-assigned for the second round of intervention, as described above). Primary outcome verbal retrieval measures, secondary neuropsychological and electroencephalography (EEG) measures, and prescreening assessments for study concussion history and contraindications for treatment will be collected prior to being assigned to a treatment arm (i.e., baseline). Magnetic resonance imaging of the brain will be obtained only at the baseline assessment.

Primary outcome verbal retrieval measures and secondary neuropsychological and electroencephalography (EEG) measures will be collected after treatment session 10 and one time following treatment competition (i.e., 2-months). For participants who complete the second round of intervention, primary outcome verbal memory measures and secondary neuropsychological and electroencephalography (EEG) measures will be collected again after treatment session 10 and one time following competition of the second treatment (i.e., 2-months).

Eligibility

Inclusion Criteria: Participants are to be between the ages of 18-85, are non-military

        personnel and not veterans, and have had a traumatic brain injury (more than a year ago
        prior to study participation) that has led to a complaint of word finding difficulty since
        the brain injury, confirmed to represent a verbal retrieval deficit based on
        neuropsychological testing criteria. Traumatic brain injury must be in the mild to moderate
        range based on evaluation, including the Ohio State TBI Identification Method (administered
        by our research group). You must be fluent in speaking and reading English.
        Exclusion Criteria:
          -  an implanted/electronic device, such as a pacemaker, metallic cranial or intracranial
             implant (e.g., ventriculoperitoneal shunt), or a neurostimulator (e.g., vagus nerve
             stimulator, spinal stimulator, deep brain stimulator, etc.).
          -  skull defects
          -  a history of a psychological or neurological disorder, including, dementia of any
             type, epilepsy or other seizure disorders, post-traumatic stress disorder, brain
             tumor, present drug abuse, stroke, blood vessel abnormalities in the brain,
             Parkinson's disease, Huntington's disease, or multiple sclerosis.
          -  inability to give informed consent
          -  currently pregnant
          -  not a native English speaker

Study details

Traumatic Brain Injury, Word Finding Difficulty, Acquired Brain Injury, Cognitive Change

NCT05408975

The University of Texas at Dallas

29 April 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.